The balanced chromosomal translocation t(8;21) is found in about 90% of acute myeloid leukemia (AML) patients. AML is a heterogeneous clonal disorder of hematopoietic progenitor cells and one of the most common malignant myeloid disorders in adults. The runt related transcription factor 1 gene (RUNX1) and RUNX1 translocation partner 1 (RUNX1T1) gene are both involved in the transcriptional regulation of genes during normal hematopoiesis. The non-random translocation t(8;21) (q21.3;q22.1) is strongly associated with the French-American-British (FAB) phenotype M2 (AML-M2) and produces a chimeric gene consisting of the 5‘-region of the RUNX1 gene fused to the 3‘-region of the RUNX1T1 gene. The chimeric protein is thought to be associated with the nuclear corepressor/histone deacetylase complex to block hematopoietic differentiation. Fluorescence in situ Hybridization (FISH) can provide important information for the management of patients with hematologic disorders.